Characterization of Bangerter filter effect in mild and moderate anisometropic amblyopia: predictive factors for the visual outcome

  • Carlos Laria
  • David P. PiñeroEmail author
  • Jorge L. Alió



To evaluate the outcome achieved by using Bangerter filters in cases of mild and moderate anisometropic amblyopia, and to define the predictive factors for the final visual outcome.


Prospective study comprising 62 children (age range 3–11 years) with unilateral amblyopia associated with myopic or hyperopic anisometropia. In all cases, the use of Bangerter filters were prescribed for amblyopia treatment due to the unsuccessful outcome with refractive correction. The prescribed filter always induced a visual acuity reduction in the non-amblyopic eye of 2 lines below the BSCVA of the amblyopic eye. A follow-up of 12 months was completed.


A statistically significant improvement in visual acuity was observed at 3 months in both groups, amblyopic and non-amblyopic eyes (p < 0.01). At 6, 9 and 12 months, additional small but statistically significant improvements in visual acuity were detected only in the amblyopic group (p ≤ 0.02). Filter density had to be changed during the follow-up in a total of 22 eyes (35.5%). A significant correlation of the visual acuity with the baseline interocular visual acuity difference was found at 3 months (r = 0.44, p < 0.01), but not at the end of the follow-up (r = 0.12, p = 0.36). Multiple linear regression analysis revealed that the final visual outcome was significantly correlated with the baseline visual acuity, sphere and the difference in visual acuity between eyes (R2: 0.42, p < 0.01).


Bangerter filters are useful for treating mild or moderate amblyopia due to anisometropia, but ocular dominance inversion should be maintained during treatment for obtaining an optimized outcome.


Amblyopia Bangerter filter 


  1. 1.
    Loudon E, Simons HJ (2005) The history of the treatment of amblyopia. Strabismus 13:93–106PubMedCrossRefGoogle Scholar
  2. 2.
    Ciuffreda KJ, Levi D, Selenow A (1991) Amblyopia: basic and clinical aspects. Chapter 1: history, definitions, classifications and prevalence. Butterworth-Heinemann, Boston, pp 1-42Google Scholar
  3. 3.
    Pediatric Eye Disease Investigator Group (2006) Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 113:895–903CrossRefGoogle Scholar
  4. 4.
    Pediatric Eye Disease Investigator Group (2005) Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 123:437–447CrossRefGoogle Scholar
  5. 5.
    Stewart CE, Moseley MJ, Fielder AR, Stephens DA, Cooperative MOTAS (2004) Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 88:1552–1556PubMedCrossRefGoogle Scholar
  6. 6.
    Alió J, Laria C (2007) Diagnosis and treatment of amblyopia. In: Garg A, Prost ME, Azad R (eds) Surgical and medical management of pediatric ophthalmology. Jaypee Brothers Medical Publishers Ltd, New Delhi, pp 855-874Google Scholar
  7. 7.
    Menon V, Shailesh G, Sharma P, Saxena R (2008) Clinical trial of patching versus atropine penalization for the treatment of anisometropic amblyopia in older children. J AAPOS 12:493–497PubMedCrossRefGoogle Scholar
  8. 8.
    Pediatric Eye Disease Investigator Group (2006) A randomized trial to evaluate 2 hours of daily patching for strabismic and anisometropic amblyopia in children. Ophthalmology 113:904–912CrossRefGoogle Scholar
  9. 9.
    Pediatric Eye Disease Investigator Group (2005) A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS 9:129–136CrossRefGoogle Scholar
  10. 10.
    Pediatric Eye Disease Investigator Group (2003) A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia, and other factors. Ophthalmology 110:1632–1638CrossRefGoogle Scholar
  11. 11.
    Pediatric Eye Disease Investigator Group (2002) A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol 120:268–278Google Scholar
  12. 12.
    Keech RV, Ottar W, Zhang L (2002) The minimum occlusion trial for the treatment of amblyopia. Ophthalmology 109:2261–2264PubMedCrossRefGoogle Scholar
  13. 13.
    Moseley MJ, Fielder AR, Irwin M, Jones HS, Auld RJ (1997) Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study. Br J Ophthalmol 81:956–961PubMedCrossRefGoogle Scholar
  14. 14.
    Foley-Nolan A, McCann A, O’Keefe M (1997) Atropine penalization vs. occlusion as the primary treatment for amblyopia. Br J Ophthalmol 81:54–57PubMedCrossRefGoogle Scholar
  15. 15.
    Repka MX, Kraker RT, Beck RW, Birch E, Cotter SA, Holmes JM, Hertle RW, Hoover DL, Klimek DL, Marsh-Tootle W, Scheiman MM, Suh DW, Weakley DR, Pediatric Eye Disease Investigator Group (2009) Treatment of severe amblyopia with weekend atropine: Results from 2 randomized clinical trials. J AAPOS 13:258–263PubMedCrossRefGoogle Scholar
  16. 16.
    Kaye SB, Kaye LC, Noonan C, Tripathi A, Ashwin P, Cota N, Clark D, Butcher J (2002) Combined optical and atropine penalization for the treatment of strabismic and anisometropic amblyopia. J AAPOS 6:289–293PubMedCrossRefGoogle Scholar
  17. 17.
    Simons K, Stein L, Sener EC, Vitale S, Guyton DL (1997) Full-time atropine, intermittent atropine, optical penalization, binocular outcome in treatment of strabismic amblyopia. Ophthalmology 104:2143–2145PubMedGoogle Scholar
  18. 18.
    France TD, France LW (1999) Optical penalization can improve vision after occlusion treatment. J AAPOS 3:341–343PubMedCrossRefGoogle Scholar
  19. 19.
    McIntyre A, Fells P (1996) Bangerter foils: A new approach to the management of pathological intractable diplopia. Br Orthopt J 53:43–47Google Scholar
  20. 20.
    Bangerter A (1960) Die Okklusion in der Pleoptik und Orthoptik. Klin Monatsbl Augenheilkd 136:305–331Google Scholar
  21. 21.
    Bangerter A (1946) Behandlung der Amblyopie. Ophthalmologica 111:220CrossRefGoogle Scholar
  22. 22.
    Pediatric Eye Disease Investigator Group (2003) Impact of patching and atropine treatment on the child and family in the Amblyopia Treatment Study. Arch Ophthalmol 121:1625–1632CrossRefGoogle Scholar
  23. 23.
    Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ (1995) Compliance in amblyopia therapy: objective monitoring of occlusion. Br J Ophthalmol 79:585–589PubMedCrossRefGoogle Scholar
  24. 24.
    Campos EC, Chiesi C, Rozzi N (1991) Intossicazione da atropina in corso di terapia antiambliopica. G It Ortotte Tec Strum Oft 8:185–188Google Scholar
  25. 25.
    Lowe RF (1965) Atropine treatment for amblyopia ex anopsia. Br Orthopt J 22:35–42Google Scholar
  26. 26.
    Abraham SV (1954) Intraepithelial cysts of the iris. Am J Ophthalmol 37:327–331PubMedGoogle Scholar
  27. 27.
    Pediatric Eye Disease Investigator Group Writing Committee, Rutstein RP, Quinn GE, Lazar EL, Beck RW, Bonsall DJ, Cotter SA, Crouch ER, Holmes JM, Hoover DL, Leske DA, Lorenzana IJ, Repka MX, Suh DW (2010) A randomized trial comparing Bangerter filters and patching for the treatment of moderate amblyopia in children. Ophthalmology 117(5):998–1004PubMedCrossRefGoogle Scholar
  28. 28.
    Agervi P, Kugelberg U, Kugelberg M, Simonsson G, Fornander M, Zetterström C (2009) Treatment of anisometropic amblyopia with spectacles or in combination with translucent Bangerter filters. Ophthalmology 116:1475–1480PubMedCrossRefGoogle Scholar
  29. 29.
    Holladay JT (1997) Proper method for calculating average visual acuity. J Refract Surg 13:388–391PubMedGoogle Scholar
  30. 30.
    North RV, Kelly ME (1991) Atropine occlusion in the treatment of strabismic amblyopia and its effect on the non-amblyopic eye. Ophthalmic Physiol Opt 11:113–117PubMedCrossRefGoogle Scholar
  31. 31.
    Agervi P, Kugelberg U, Kugelberg M, Simonsson G, Fornander M, Zetterström C (2010) Randomized evaluation of spectacles plus alternate-day occlusion to treat amblyopia. Ophthalmology 117:381–387PubMedCrossRefGoogle Scholar
  32. 32.
    Dorey SE, Adams GG, Lee JP, Sloper JJ (2001) Intensive occlusion therapy for amblyopia. Br J Ophthalmol 85:310–313PubMedCrossRefGoogle Scholar
  33. 33.
    Moseley MJ, Fielder AR, Irwin M, Jones HS, Auld RJ (1997) Effectiveness of occlusion therapy in ametropic amblyopia: a pilot study. Br J Ophthalmol 81:956–961PubMedCrossRefGoogle Scholar
  34. 34.
    Odell NV, Leske DA, Hatt SR, Adams WE, Holmes JM (2008) The effect of Bangerter filters on optotype acuity, Vernier acuity, and contrast sensitivity. J AAPOS 12:555–559PubMedCrossRefGoogle Scholar
  35. 35.
    Arikan G, Yaman A, Berk AT (2005) Efficacy of occlusion treatment in amblyopia and clinical risk factors affecting the results of treatment. Strabismus 13:63–69PubMedCrossRefGoogle Scholar
  36. 36.
    Hussein MA, Coats DK, Muthialu A, Cohen E, Paysse EA (2004) Risk factors for treatment failure of anisometropic amblyopia. J AAPOS 8:429–434PubMedCrossRefGoogle Scholar
  37. 37.
    Mazow ML, Chuang A, Vital MC, Prager T (2000) 1999 Costenbander Lecture. Outcome study in amblyopia: treatment and practice pattern variations. J AAPOS 4:1–9PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Carlos Laria
    • 1
  • David P. Piñero
    • 1
    • 2
    Email author
  • Jorge L. Alió
    • 1
    • 3
  1. 1.Vissum/Instituto Oftalmológico de AlicanteAlicanteSpain
  2. 2.Departamento de Óptica, Farmacología y AnatomíaUniversidad de AlicanteAlicanteSpain
  3. 3.Division of OphthalmologyUniversidad Miguel HernándezAlicanteSpain

Personalised recommendations